Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

Journal of the American College of Cardiology - 19 Sept 2006

McNamara Dennis M, Tam S William, Sabolinski Michael L, Tobelmann Page, Janosko Karen, Taylor Anne L, Cohn Jay N, Feldman Arthur M, Worcel Manuel

Abstract excerpt

OBJECTIVES: We sought to evaluate the effect of the aldosterone synthase promoter polymorphism on heart failure outcomes for subjects in the African American Heart Failure Trial (A-HeFT). BACKGROUND: Genetic heterogeneity modulates clinical outcomes in subjects with heart failure (HF); however, l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Cytochrome P-450 CYP11B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homozygote

Share to Hospitalization

Share to Predictive Value of Tests

Share to Survival Analysis

Share to Vasodilator Agents

Share to Ventricular Remodeling

Source

Identifiers

PMID: 16979018
DOI: 10.1016/j.jacc.2006.07.030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16979018-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.PMID 16979018Read ↗

Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure.Semantic proximity Read ↗

Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failure.Semantic proximity Read ↗

Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure.Semantic proximity Read ↗

Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population.Semantic proximity Read ↗

Emerging role of pharmacogenomics in heart failure.Semantic proximity Read ↗

Race, common genetic variation, and therapeutic response disparities in heart failure.Semantic proximity Read ↗

Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.Semantic proximity Read ↗

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.Semantic proximity Read ↗

Exploring the Role of Genetic and Genomic Factors in Therapeutic Response to Heart Failure: A Comprehensive Analytical ReviewSemantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.Semantic proximity Read ↗

Genetics and pharmacogenetics in heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.